CADL250117C14000
- 0.15
- 0.000.00%
Candel Therapeutics Newsroom
Insider Stock Buying Of Candel Therapeutics Delivers Return On US$3.00m Investment
Candel Therapeutics Provides Clinical and Financial Update, Outlines 2025 Milestones for CAN-2409 and CAN-3110 Programs
Candel Therapeutics Provides Corporate Update and Highlights Strong Pipeline Momentum and Key Value Drivers for 2025
How Is The Market Feeling About Candel Therapeutics?
2025 Biotech Outlook: Small-cap Innovators Tackling Chronic and Rare Diseases | NASDAQ:CADL
Why FedEx Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Candel Therapeutics(CADL.US) Director Buys US$7.5 Million in Common Stock
Candel Therapeutics Aims to Transform Cancer Outcomes | NASDAQ:CADL
HC Wainwright & Co. Reiterates Buy on Candel Therapeutics, Raises Price Target to $19
Candel Therapeutics Analyst Ratings
H.C. Wainwright Maintains Candel Therapeutics(CADL.US) With Buy Rating, Raises Target Price to $19
Express News | Candel Therapeutics, Inc. : H.c. Wainwright Raises Target Price to $19 From $11
Candel Therapeutics Inc Call Volume Above Normal and Directionally Bullish
Candel Therapeutics Closes Securities Offering to Raise $92 Million
Press Release: Candel Therapeutics Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
What's Going On With Candel Therapeutics Shares Friday?
Sector Update: Health Care Stocks Steady Premarket Friday
Wall Street Set to Open Higher Friday as Investors Shake Off Bad Week
Candel Therapeutics, 8x8 And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Investors Look to End Week on Strong Note as US Futures Rise in Friday's Premarket